BIOLASE, Inc. (BIOL) Q3 2022 Earnings Call Transcript

BIOLASE, Inc. (BIOL) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET

Company Participants

Todd Kehrli - Investor Relations
John Beaver - President and Chief Executive Officer
Jennifer Bright - Chief Financial Officer

Conference Call Participants

Kyle Bauser - Lake Street Capital Markets
Anthony Vendetti - the Maxim Group
Bruce Jackson - The Benchmark Company

Operator

Good day and welcome to the BIOLASE Third Quarter 2022 Financial Results Conference Call. Please note, this call is being recorded. [Operator Instructions] I would now like to turn the call over to Todd Kehrli of the EVC Group. Please go ahead.

Todd Kehrli

Thank you, operator. Good afternoon, everyone and thank you for joining us today to discuss BIOLASE’s financial results for the third quarter ended September 30, 2022. On the call today from BIOLASE are John Beaver, President and Chief Executive Officer; and Jennifer Bright, Chief Financial Officer. John will review the company’s operating performance for the third quarter and then turn the call over to Jennifer to review the financials in more detail before opening the call for questions.

Before we begin, I’d like to remind everyone that a number of forward-looking statements, which are statements that are not historical facts, will be made during this presentation and subsequent Q&A session, including forward-looking statements regarding the company’s strategic initiatives and anticipated financial performance. These forward-looking statements are defined under the Private Securities Litigation Reform Act of 1995 and are based on BIOLASE’s current expectations and assumptions and are subject to a variety of risks and uncertainties that could cause the company’s actual results to differ materially from the statements made.

Such forward-looking statements only represent the company’s view as of today, November 10, 2022. These risks are discussed in the Risk Factors section of the company’s most recent Form 10-K and Form